04:45:14 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-08 Kvartalsrapport 2024-Q3
2024-08-23 Kvartalsrapport 2024-Q2
2024-05-14 Kvartalsrapport 2024-Q1
2024-04-29 X-dag ordinarie utdelning OMDA 0.48 NOK
2024-04-25 Årsstämma 2024
2024-03-01 Bokslutskommuniké 2023
2023-11-10 Kvartalsrapport 2023-Q3
2023-09-26 Extra Bolagsstämma 2023
2023-08-25 Kvartalsrapport 2023-Q2
2023-05-12 Kvartalsrapport 2023-Q1
2023-04-28 X-dag ordinarie utdelning OMDA 0.00 NOK
2023-04-27 Årsstämma 2023
2023-02-28 Bokslutskommuniké 2022
2022-11-30 Kvartalsrapport 2022-Q3
2022-10-03 Extra Bolagsstämma 2022
2022-08-30 Kvartalsrapport 2022-Q2
2022-05-20 X-dag ordinarie utdelning OMDA 0.00 NOK
2022-05-19 Kvartalsrapport 2022-Q1
2022-05-19 Årsstämma 2022
2022-02-25 Bokslutskommuniké 2021
2021-11-26 Kvartalsrapport 2021-Q3
2021-08-31 Kvartalsrapport 2021-Q2
2021-05-26 Kvartalsrapport 2021-Q1
2021-05-07 X-dag ordinarie utdelning OMDA 0.00 NOK
2021-05-06 Årsstämma 2021
2021-02-26 Bokslutskommuniké 2020
2020-12-11 Extra Bolagsstämma 2020
2020-11-27 Kvartalsrapport 2020-Q3

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorInformationsteknik
IndustriProgramvara
OMDA är verksamma inom teknikbranschen. Bolaget är specialiserade inom utveckling av digitala plattformar för vården. Programvaran är egenutvecklad och används huvudsakligen för analys och uppföljning av olika områden inom sjukvården. Utöver huvudverksamheten erbjuds även diverse mervärdestjänster. Verksamhet innehas på global nivå med störst närvaro inom den europeiska marknaden.
2024-05-14 07:00:00
Oslo, Norway, 14 May 2024: Today, Omda AS ("Omda"), a leading provider of
specialised software for healthcare and emergency response, published its
results for the first quarter of 2024.

Omda continues to deliver profitable growth and Q1-24 saw revenues growing
organically 5%, reaching NOK 106 million.

Omda CEO Sverre Flatby highlights one of the key drivers: "In the first quarter,
recurring revenue represented 79% of total sales. Our long-term relations with
leading healthcare organisations secure predictable income for the years to
come, and are a solid foundation for expanding our business."

Profitability also increased, with the EBITDA margin hitting 14%, up from 5% for
the same period last year.

Flatby is optimistic for the rest of the year: "While our Business Areas
continue to improve margins, Omda is increasing its efforts on M&A
opportunities. We have identified several attractive candidates, which are in
various stages of development. Backed by our cash reserve, last-year's bond
refinancing, and expected cash from operations going forward, we are well
positioned to act on the right opportunities."

Highlights from the report:
o Q1-24 total income 106 MNOK vs 102 MNOK in Q1-23
o Reported EBITDA was 15 MNOK resulting in a 14% EBITDA margin for Q1-24,
compared to 5% in Q1-23
o Recurring revenue of 83 MNOK vs 79 MNOK in Q1-23, accounting for 79% of total
sales
o Q1-24 organic growth of 5% in local currency vs Q1-23 (7% in NOK)
o Gross margin of 93% compared to 92% in Q1-23

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@omda.com

About Omda
Omda is the leading provider of specialised software for healthcare and
emergency services in the Nordics with a growing presence in Europe, North
America and the Pacific region. The company has more than 500 customers in 27
countries and employs almost 300 dedicated specialists. Our highly specialised
healthcare solutions empower medical professionals and emergency responders,
enabling them to know more and work smarter. With a focus on user-centric
design, value-driven development and close working relationships with customers,
Omda delivers solutions that enhance patient safety and improve healthcare
outcomes.

For more information, visit www.omda.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH